Global Vaccine Market to 2022

The report package Global Vaccine Market to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in the world.

Along with a global vaccines market report, the package includes country reports from the following countries:Belgium, Brazil, China, France, India, Japan, Pakistan, South Korea, United Kingdom, United States

The research includes historical data from 2011 to 2017 and forecasts until 2022 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

The reports help answer the following questions:- What is the size of the vaccine market in the world and in the top 10 global countries?- How is the market split into different types of vaccines?- How are the overall market and different product types growing?- How is the market predicted to develop in the future?

The latest industry data included in the reports:- Demand for vaccines, 2011-2022- Vaccine market size by product type, 2011-2022- Growth rates of the overall market and different product segments, 2011-2022- Shares of different product segments of the overall market, 2011, 2017, and 2022

The market data is given for the following product segments:Human vaccinesVeterinary vaccines

Among the key reasons to purchase include the following:- Gain an outlook of the historical development, current market situation, and future outlook of the vaccine market in the world to 2022- Track industry developments and identify market opportunities- Plan and develop marketing, market-entry, market expansion, and other business strategies by identifying the key market opportunities and prospects- Save time and money with the readily accessible key market data included in the reports. The data is clearly presented and can be easily incorporated into presentations and internal reports.

The North American biodefense market is estimated to reach US$ 3,357.83 Mn by 2027 from US$ 1,569.29 Mn in 2019; it is projected to grow at a CAGR of 10.1% from 2019 to 2027. The growth of the biodefense market is primarily ascribed to the presence of favorable government initiatives and increase in the number of naturally occurring outbreaks....

The veterinary vaccines market is projected to grow at a CAGR of 7.2% during the forecast period (2020–2025). The global veterinary vaccines market size is projected to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020, at a CAGR of 7.2%. The growth of this market is driven majorly by factors such as the initiatives by various...

"The global COVID 19 vaccines market is projected to grow at a CAGR of -14.9% during the forecast period." The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the global COVID-19 vaccines market is majorly attributed...

Overview Global sales of neuromodulation systems for the treatment of movement disorders (Parkinson’s disease, essential tremor, and dystonia) and epilepsy, which include implantable deep brain stimulation (DBS) and vagus nerve stimulation (VNS) devices, respectively, are expected to increase at a CAGR of approximately...

The Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2020: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right...

By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.

You can change your Cookie Settings at any time but parts of our site will not function correctly without them.